Published in Obesity and Diabetes Week, March 7th, 2005
"Metformin (1,1-dimethylbiguanide) is an antihyperglycemic drug used to normalize glucose concentrations in type 2 diabetes. Furthermore, antioxidant benefits have been reported in diabetic patients treated with metformin. This work was aimed at studying the scavenging capacity of this drug against reactive oxygen species (ROS) like .OH and O2 .-free radicals," scientists writing in the European Journal of Biochemistry report.
"ROS were produced by gamma radiolysis of water," said Hania Khouri at the University of Paris 5 and collaborators...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Obesity and Diabetes Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.